Latest News

A study by UCLA researchers is the first to demonstrate a technique for coaxing pluripotent stem cells — which can give rise to every cell type in the body and which can be grown indefinitely in the lab — into becoming mature T cells capable of killing tumor cells.

January 17, 2019 3:00 PM

In this Q&A, Paul Boutros explains how scientists take data, such as DNA sequencing, to design personal treatments

January 16, 2019 8:00 AM

Researchers have discovered molecular hallmarks of hypoxia in the first-ever pan-cancer analysis of low oxygen in human tumors, with a special focus on prostate cancer.

January 14, 2019 8:00 AM

UCLA scientists have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism.

January 09, 2019 11:00 AM

Dr. Linda Liau, chair of the neurosurgery department at the David Geffen School of Medicine at UCLA, has been awarded the Abhijit Guha Award for her pioneering work on treating brain tumors.

December 21, 2018 8:30 AM

Dr. Siavash Kurdistani has been elected as members of the American Society for Clinical Investigation, one of the oldest and most esteemed nonprofit honor societies of physician-scientists.

December 20, 2018 9:00 AM

A new study by UCLA scientists shows that enhancers, snippets of DNA that contribute to gene regulation, fall into the same “insulated neighborhoods” or chromatin loops as the target gene and other gene-specific regulatory elements.

December 10, 2018 11:00 AM

A UCLA-led research team has developed a spray gel embedded with immune-boosting drugs that could help fight recurrent cancer.

December 10, 2018 9:00 AM

Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute of Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the molecules that help form cells’ outer membranes.

December 05, 2018 10:00 AM

UCLA researchers have found that commonly used hormone therapies for women diagnosed with breast cancer do not appear to cause significant cognitive dysfunction following the treatment.

November 28, 2018 11:00 AM

Carla Koehler, a professor with the Department of Chemistry and Biochemistry, has been named a Fellow of the American Association for the Advancement of Science. Koehler’s election is an honor bestowed on her by her peers within the Association.

November 27, 2018 10:00 AM

The newly FDA-approved larotrectinib is a targeted cancer therapy. UCLA treated “Little Linda” as part of a trial. She had infantile fibrosacoma. Within days of beginning her treatment, the tumor started shrinking.

November 26, 2018 2:00 PM

UCLA researchers conducted a study of breast cancer survivors to better understand if lower activity of telomerase (an enzyme that helps maintain the health of cells) along with DNA damage (a factor in cellular aging) were associated with worse cognitive performance, such as attention and motor skills.

November 26, 2018 10:00 AM

Dr. Hans David Ulmert, a new member of the UCLA Jonsson Comprehensive Cancer Center, is being honored by the Society for Basic Urologic Research with their annual Young Investigator Awards.

November 15, 2018 9:00 AM

UCLA scientists have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth.

November 14, 2018 11:00 AM

A group of researchers from the UCLA Jonsson Comprehensive Cancer Center received a $3.5 million, five-year grant from the National Institute of Health to create a center dedicated to developing an effective and affordable blood-based cancer-screening test to help detect liver cancer early.

November 07, 2018 9:00 AM

Something as simple as a change in diet can potentially help to increase the cancer survival rate of obese children with acute lymphoblastic leukemia, the most common childhood cancer, according to a new study by UCLA scientists.

October 31, 2018 6:00 PM

Denise Delatorre felt a lump in her stomach that she knew was serious. She was diagnosed with non-Hodgkin’s lymphoma, one of the most common blood cancers. When chemotherapy didn’t work, she enrolled in UCLA’s first CAR T clinical trial. Today, Denise is in sustained remission. This is her story.

October 31, 2018 11:00 AM

UCLA researchers have discovered a new protein factor that contributes to a fibroblast cell’s ability to migrate to a wound and participate in its healing process. The study’s results could help scientists prevent cancer cells from using the same mechanisms to move throughout the body and spread.

October 29, 2018 11:00 AM

UCLA researchers have discovered a new protein factor that contributes to a fibroblast cell’s ability to migrate to a wound and participate in its healing process. The study’s results could help scientists prevent cancer cells from using the same mechanisms to move throughout the body and spread.

October 26, 2018 9:00 AM